Article Details
Retrieved on: 2025-03-13 18:44:43
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article details United Health Products' efforts in capital markets and regulatory processes, including an OTCQB market application to enhance liquidity. It emphasizes funding activities, FDA Investigational Device Exemption for clinical trials, and implications for their product in medical markets.
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here